luzindole has been researched along with 5-methoxyluzindole in 3 studies
| Studies (luzindole) | Trials (luzindole) | Recent Studies (post-2010) (luzindole) | Studies (5-methoxyluzindole) | Trials (5-methoxyluzindole) | Recent Studies (post-2010) (5-methoxyluzindole) |
|---|---|---|---|---|---|
| 265 | 1 | 119 | 5 | 0 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubocovich, ML; Iacob, S; Masana, MI; Sauri, DM | 1 |
| Cecon, E; Jockers, R; Rivara, S; Witt-Enderby, PA; Zlotos, DP | 1 |
| Dubocovich, ML; Duncan, MJ; Fang, JM | 1 |
3 other study(ies) available for luzindole and 5-methoxyluzindole
| Article | Year |
|---|---|
Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.
Topics: Animals; Cell Line; Humans; In Vitro Techniques; Iodine Radioisotopes; Kinetics; Melatonin; Rabbits; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; Receptors, Presynaptic; Recombinant Proteins; Retina | 1997 |
MT1 and MT2 melatonin receptors: ligands, models, oligomers, and therapeutic potential.
Topics: Animals; Binding Sites; Depressive Disorder; Humans; Ligands; Melatonin; Models, Molecular; Protein Multimerization; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship | 2014 |
Effects of melatonin agonists and antagonists on reproduction and body weight in the Siberian hamster.
Topics: Animals; Binding, Competitive; Body Weight; Cricetinae; Light; Male; Median Eminence; Melatonin; Methysergide; Organ Size; Periodicity; Pituitary Gland, Anterior; Receptors, Melatonin; Receptors, Neurotransmitter; Testis; Tryptamines | 1990 |